TAYLOR BEN R (Chief Financial Officer) sold 0.7% of their position (7.96K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $27.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/18/2026ACC: 0001712276-26-000002
Officer· Chief Financial Officer
Since Feb 2026
-15.03K
Net shares
Net seller
$51.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
15.03K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−7.08K
Price / share
$3.42
Trade value
$24.20K
% of position
0.6%
3/16/2026
1.20M→1.19M
Class A Common Stock
Direct
Shares
−7.96K
Price / share
$3.39
Trade value
$26.97K
% of position
0.7%
3/17/2026
1.19M→1.18M
Total
Net shares
−15.03K
Net value
-$51.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/16/2026 | F · Tax Withholding | −7.08K | $3.42 | $24.20K | 0.6% | 1.20M | 1.19M |
| Class A Common Stock Direct | 3/17/2026 | S · Sale | −7.96K | $3.39 | $26.97K | 0.7% | 1.19M | 1.18M |
| Total | −15.03K | -$51.17K | ||||||
Derivative Transactions0
No derivative transactions reported